Clinical Trial Update: Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating docetaxel with androgen deprivation therapy and external-beam radiation in men with high-risk localized prostate cancer. The study ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Androgen deprivation therapy (Androgen deprivation therapy)
• DOCETAXEL (DOCETAXEL)
• External beam radiation therapy

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-06-01